155 related articles for article (PubMed ID: 37233956)
1. ATAD2 promotes glycolysis and tumor progression in clear cell renal cell carcinoma by regulating the transcriptional activity of c-Myc.
Wu Z; Ge L; Song Y; Deng S; Duan P; Du T; Wu Y; Zhang Z; Hou X; Ma L; Zhang S
Discov Oncol; 2023 May; 14(1):79. PubMed ID: 37233956
[TBL] [Abstract][Full Text] [Related]
2. METTL13 inhibits progression of clear cell renal cell carcinoma with repression on PI3K/AKT/mTOR/HIF-1α pathway and c-Myc expression.
Liu Z; Sun T; Piao C; Zhang Z; Kong C
J Transl Med; 2021 May; 19(1):209. PubMed ID: 33985542
[TBL] [Abstract][Full Text] [Related]
3. ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway.
Xu J; Wang Y; Jiang J; Yin C; Shi B
J Transl Med; 2023 Jan; 21(1):56. PubMed ID: 36717944
[TBL] [Abstract][Full Text] [Related]
4. PRMT7 promotes the growth of renal cell carcinoma through modulating the β-catenin/C-MYC axis.
Liu F; Wan L; Zou H; Pan Z; Zhou W; Lu X
Int J Biochem Cell Biol; 2020 Mar; 120():105686. PubMed ID: 31926310
[TBL] [Abstract][Full Text] [Related]
5. HSP60 silencing promotes Warburg-like phenotypes and switches the mitochondrial function from ATP production to biosynthesis in ccRCC cells.
Teng R; Liu Z; Tang H; Zhang W; Chen Y; Xu R; Chen L; Song J; Liu X; Deng H
Redox Biol; 2019 Jun; 24():101218. PubMed ID: 31112866
[TBL] [Abstract][Full Text] [Related]
6. SPTBN1 abrogates renal clear cell carcinoma progression via glycolysis reprogramming in a GPT2-dependent manner.
Wu J; Miao C; Wang Y; Wang S; Wang Z; Liu Y; Wang X; Wang Z
J Transl Med; 2022 Dec; 20(1):603. PubMed ID: 36527113
[TBL] [Abstract][Full Text] [Related]
7. N-Myc downstream-regulated gene 2 restrains glycolysis and glutaminolysis in clear cell renal cell carcinoma.
Shi W; Xu X; Yan F; Wang B; Zhao H; Chan A; Ren Z; Ma Y; Wang F; Yuan J
Oncol Lett; 2017 Dec; 14(6):6881-6887. PubMed ID: 29163707
[TBL] [Abstract][Full Text] [Related]
8. PCK1 Regulates Glycolysis and Tumor Progression in Clear Cell Renal Cell Carcinoma Through LDHA.
Shi L; An S; Liu Y; Liu J; Wang F
Onco Targets Ther; 2020; 13():2613-2627. PubMed ID: 32280238
[TBL] [Abstract][Full Text] [Related]
9. MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells.
Tang SW; Chang WH; Su YC; Chen YC; Lai YH; Wu PT; Hsu CI; Lin WC; Lai MK; Lin JY
Cancer Lett; 2009 Jan; 273(1):35-43. PubMed ID: 18809243
[TBL] [Abstract][Full Text] [Related]
10. Traditional Chinese medicine Bu-Shen-Jian-Pi-Fang attenuates glycolysis and immune escape in clear cell renal cell carcinoma: results based on network pharmacology.
Zheng J; Xu W; Liu W; Tang H; Lu J; Yu K; Song X; Li F; Wang Y; Wang R; Chen L; Zhang H; Qiu Y; Wei G; Zhou X; Yang J
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34002799
[TBL] [Abstract][Full Text] [Related]
11. A novel NSUN5/ENO3 pathway promotes the Warburg effect and cell growth in clear cell renal cell carcinoma by 5-methylcytosine-stabilized ENO3 mRNA.
Wang J; Ju HJ; Zhang F; Tian H; Wang WG; Ma YL; Xu WS; Wang YH
Am J Transl Res; 2023; 15(2):878-895. PubMed ID: 36915728
[TBL] [Abstract][Full Text] [Related]
12. c-Myc modulates glucose metabolism via regulation of miR-184/PKM2 pathway in clear-cell renal cell carcinoma.
Huang J; Kong W; Zhang J; Chen Y; Xue W; Liu D; Huang Y
Int J Oncol; 2016 Oct; 49(4):1569-75. PubMed ID: 27431728
[TBL] [Abstract][Full Text] [Related]
13. LINC00511 promotes the malignant phenotype of clear cell renal cell carcinoma by sponging microRNA-625 and thereby increasing cyclin D1 expression.
Deng H; Huang C; Wang Y; Jiang H; Peng S; Zhao X
Aging (Albany NY); 2019 Aug; 11(16):5975-5991. PubMed ID: 31434797
[TBL] [Abstract][Full Text] [Related]
14. The long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axis.
Zhou Y; Zhang Z; Wo M; Xu W
Bioengineered; 2021 Dec; 12(1):8994-9005. PubMed ID: 34643163
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
16. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
17. circCHST15 is a novel prognostic biomarker that promotes clear cell renal cell carcinoma cell proliferation and metastasis through the miR-125a-5p/EIF4EBP1 axis.
Gui CP; Liao B; Luo CG; Chen YH; Tan L; Tang YM; Li JY; Hou Y; Song HD; Lin HS; Xu QH; Yao GS; Yao HH; Xi-Liu ; Luo JH; Cao JZ; Wei JH
Mol Cancer; 2021 Dec; 20(1):169. PubMed ID: 34922539
[TBL] [Abstract][Full Text] [Related]
18. Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.
Raeder MB; Birkeland E; Trovik J; Krakstad C; Shehata S; Schumacher S; Zack TI; Krohn A; Werner HM; Moody SE; Wik E; Stefansson IM; Holst F; Oyan AM; Tamayo P; Mesirov JP; Kalland KH; Akslen LA; Simon R; Beroukhim R; Salvesen HB
PLoS One; 2013; 8(2):e54873. PubMed ID: 23393560
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of ERp57 promotes clear cell renal cell carcinoma progression by initiating a STAT3/ILF3 feedback loop.
Liu Y; Wang JX; Nie ZY; Wen Y; Jia XJ; Zhang LN; Duan HJ; Shi YH
J Exp Clin Cancer Res; 2019 Oct; 38(1):439. PubMed ID: 31747963
[TBL] [Abstract][Full Text] [Related]
20. Elevated Expression of ADAP2 is Associated With Aggressive Behavior of Human Clear-Cell Renal Cell Carcinoma and Poor Patient Survival.
Qiang Y; Wang X; Ding J; Wang Z; Li B; Ji H; Zhang X; Yang Y; Liu K; Zhang L; Ma S; Zhao D; Lu G
Clin Genitourin Cancer; 2023 Apr; 21(2):e78-e91. PubMed ID: 36127253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
